SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051275
Filing Date
2020-11-05
Accepted
2020-11-05 16:00:42
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20200930.htm   iXBRL 10-Q 2788336
2 EX-31.1 svra-ex311_8.htm EX-31.1 14787
3 EX-31.2 svra-ex312_6.htm EX-31.2 14570
4 EX-32.1 svra-ex321_7.htm EX-32.1 10804
  Complete submission text file 0001564590-20-051275.txt   9625570

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA svra-20200930.xsd EX-101.SCH 74091
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20200930_cal.xml EX-101.CAL 52537
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20200930_def.xml EX-101.DEF 190869
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20200930_lab.xml EX-101.LAB 500916
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20200930_pre.xml EX-101.PRE 355907
10 EXTRACTED XBRL INSTANCE DOCUMENT svra-10q_20200930_htm.xml XML 1833079
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 201290288
SIC: 2834 Pharmaceutical Preparations